Aarti Pharmalabs (NSE:AARTIPHARM) Other Current Receivables: ₹5 Mil (As of Mar. 2026)


NSE:AARTIPHARM Aarti Pharmalabs Ltd NSE:AARTIPHARM
57 GF Score
Price ₹709.45
GF Value ₹643.46
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Aarti Pharmalabs Other Current Receivables?

Aarti Pharmalabs NSE:AARTIPHARM +0.92% 57 Other Current Receivables is ₹5 Mil as of Mar. 2026. GuruFocus rates NSE:AARTIPHARM with a GF Score™ of 57/100 and a GF Value™ of ₹643.46 (Fairly Valued). The stock has 3 warning signs investors should review.

Aarti Pharmalabs's Other Current Receivables for the quarter that ended in Mar. 2026 was ₹5 Mil.

Aarti Pharmalabs's quarterly Other Current Receivables declined from Sep. 2025 (₹5.43 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹4.96 Mil).

Aarti Pharmalabs's annual Other Current Receivables declined from Mar. 2024 (₹121.13 Mil) to Mar. 2025 (₹103.71 Mil) and declined from Mar. 2025 (₹103.71 Mil) to Mar. 2026 (₹4.96 Mil).

Aarti Pharmalabs Other Current Receivables Related Terms

Aarti Pharmalabs Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Aarti Pharmalabs's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarti Pharmalabs Other Current Receivables Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial 126.80 66.21 121.13 103.71 4.96

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.71 0.00 5.43 0.00 4.96
NSE:AARTIPHARM
57GF Score
Aarti Pharmalabs Ltd NSE:AARTIPHARM
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aarti Pharmalabs Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹5 Mil mean?
Aarti Pharmalabs (NSE:AARTIPHARM) has a Other Current Receivables of ₹5 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Aarti Pharmalabs and its competitors.
Is Aarti Pharmalabs' Other Current Receivables too high?
Aarti Pharmalabs' current Other Current Receivables is ₹5 Mil. Overall, Aarti Pharmalabs has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aarti Pharmalabs' Other Current Receivables compare to ZTS and UTHR?
Aarti Pharmalabs' Other Current Receivables of ₹5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Aarti Pharmalabs and its competitors. Aarti Pharmalabs's current Other Current Receivables is ₹5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aarti Pharmalabs stock overvalued right now?
Based on GuruFocus' analysis, Aarti Pharmalabs (NSE:AARTIPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹643.46, compared to a current price of ₹709.45 — trading 10.3% above its estimated fair value. The current Other Current Receivables is ₹5 Mil. Aarti Pharmalabs' overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Aarti Pharmalabs (NSE:AARTIPHARM), the current Other Current Receivables is ₹5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aarti Pharmalabs (NSE:AARTIPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Aarti Pharmalabs stock appears to be overvalued. The current stock price of ₹709.45 is trading 10.3% above its estimated GF Value™ of ₹643.46. GuruFocus considers Aarti Pharmalabs to be Fairly Valued.

Key valuation signals for NSE:AARTIPHARM:

  • Other Current Receivables: ₹5 Mil
  • GF Value™: ₹643.46 vs. price of ₹709.45 (10.3% above fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the NSE:AARTIPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aarti Pharmalabs Business Description

Other Exchanges 543748:India
Address Mulund Goregaon Link Road, 204, 2nd Floor, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. The company manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, acids, and xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.
57GF Score

Get the complete analysis for NSE:AARTIPHARM

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹709.45
Price
₹643.46
GF Value